Gérard Soula

Director/Board Member at

GLOWBL SAS

Net worth: 5 M $ as of 31/08/2026

80 year

17 connections

Health Technology

Consumer Services

Technology Services

Profile

Gérard Soula was the founder of Flamel Technologies SA, founded in 1990, where the title held was Chairman & Chief Executive Officer from 1990 to 2005.
Dr. Soula was the founder of Adocia SA, founded in 2005, where the title held was Chairman, President & Chief Executive Officer from 2012 to 2023.
The current job is Director at Glowbl SAS. Former jobs include Director at Veloxis Pharmaceuticals A and Director at Life Cycle Pharma A. Education includes a doctorate from Université d'Aix-Marseille.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ADOCIA SA 5.83%	13/03/2026	1,180,192 ( 5.83% )	5 M $	31/08/2026

Gérard Soula active positions

Companies	Position	Start
GLOWBL SAS GLOWBL SAS Packaged SoftwareTechnology Services Designs and develops communications software for videoconferencing and content sharing	Director/Board Member	-

All active positions of Gérard Soula

Former positions of Gérard Soula

Companies	Position	End
Flamel Technologies SA Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs	Founder	01/01/2005
Life Cycle Pharma A/S	Director/Board Member	-
ADOCIA	Chief Executive Officer	11/05/2023
VELOXIS PHARMACEUTICALS A/S	Director/Board Member	-

See the detail of Gérard Soula's experience

Training of Gérard Soula

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gérard Soula's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Flamel Technologies SA Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs	Health Technology
Veloxis Pharmaceuticals A/S Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients	Health Technology
Adocia SA Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases	Health Technology
Life Cycle Pharma A/S
Université d'Aix-Marseille Université d'Aix-Marseille Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
GLOWBL SAS GLOWBL SAS Packaged SoftwareTechnology Services Designs and develops communications software for videoconferencing and content sharing	Technology Services